Dr Reddy's Laboratories Q2 profit falls 17 per
cent at Rs 574 cr
India's second-largest drugmaker by revenue, reported a 17 per cent drop
in its second-quarter profit, pushing its shares down nearly 3 per cent.
The company, whose formulations include drugs for cardiovascular
disorders, oncology and pain management, posted a net profit of 5.74 billion
rupees ($93.6 million) compared with 6.90 billion rupees a year earlier.
Dr Reddy's shares were down 2.5 per cent at Rs 3,004 at 0657 GMT in
Mumbai, while the broader market was up 0.4 per cent.
No comments:
Post a Comment